|
1
|
Cucinotta D and Vanelli M: WHO declares
COVID-19 a pandemic. Acta Biomed. 91:157–160. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Thompson MG, Stenehjem E, Grannis S, Ball
SW, Naleway AL, Ong TC, DeSilva MB, Natarajan K, Bozio CH, Lewis N,
et al: Effectiveness of covid-19 vaccines in ambulatory and
inpatient care settings. N Engl J Med. 385:1355–1371.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cai C, Li Y, Hu T, Liang R, Wang K, Guo C,
Li Y, Zhang M and Kang M: The associated factors of SARS-CoV-2
reinfection by Omicron variant-guangdong province, China, December
2022 to January 2023. China CDC Weekly. 5:391–396. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, Liang J, Yang H, Zhu L, Hu J, Xiao
L, Huang Y, Dong Y, Wu C, Zhang J and Zhou X: Epidemiological and
clinical characteristics of COVID-19 reinfection during the
epidemic period in Yangzhou city, Jiangsu province. Front Public
Health. 11(1256768)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chilamakuri R and Agarwal S: COVID-19:
Characteristics and therapeutics. Cells. 10(206)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bai Y and Tao X: Comparison of COVID-19
and influenza characteristics. J Zhejiang Univ Sci B. 22:87–98.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen
YS, Liang ZA, Liang L, Zhang SJ, Zhang B, et al: Clinical features
of the initial cases of 2009 pandemic influenza A (H1N1) virus
infection in China. N Engl J Med. 361:2507–2517. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yan CH, Faraji F, Prajapati DP, Boone CE
and DeConde AS: Association of chemosensory dysfunction and
COVID-19 in patients presenting with influenza-like symptoms. Int
Forum Allergy Rhinol. 10:806–813. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xu J, Kirtek T, Xu Y, Zheng H, Yao H,
Ostman E, Oliver D, Malter JS, Gagan JR and SoRelle JA: Digital
droplet PCR for SARS-CoV-2 resolves borderline cases. Am J Clin
Pathol. 155:815–822. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Alon R, Sportiello M, Kozlovski S, Kumar
A, Reilly EC, Zarbock A, Garbi N and Topham DJ: Leukocyte
trafficking to the lungs and beyond: Lessons from influenza for
COVID-19. Nat Rev Immunol. 21:49–64. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y,
Huang B, Fu S, Tan Y, Sun J and Li X: Clinical features of
maintenance hemodialysis patients with 2019 novel
coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc
Nephrol. 15:1139–1145. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee N, Hui D, Wu A, Chan P, Cameron P,
Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, et al: A major
outbreak of severe acute respiratory syndrome in Hong Kong. N Engl
J Med. 348:1986–1994. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sharon N, Talnir R, Lavid O, Rubinstein U,
Niven M, First Y, Tsivion AJ and Schachter Y: Transient lymphopenia
and neutropenia: Pediatric influenza A/H1N1 infection in a primary
hospital in Israel. Isr Med Assoc J. 13:408–412. 2011.PubMed/NCBI
|
|
14
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cobb NL, Sathe NA, Duan KI, Seitz KP, Thau
MR, Sung CC, Morrell ED, Mikacenic C, Kim HN, Liles WC, et al:
Comparison of clinical features and outcomes in critically ill
patients hospitalized with COVID-19 versus influenza. Ann Am Thorac
Soc. 18:632–640. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Klion AD, Ackerman SJ and Bochner BS:
Contributions of eosinophils to human health and disease. Annu Rev
Pathol. 15:179–209. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wechsler ME, Munitz A, Ackerman SJ, Drake
MG, Jackson DJ, Wardlaw AJ, Dougan SK, Berdnikovs S, Schleich F,
Matucci A, et al: Eosinophils in health and disease: A
state-of-the-art review. Mayo Clin Proc. 96:2694–2707.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rosenberg HF and Foster PS: Eosinophils
and COVID-19: Diagnosis, prognosis, and vaccination strategies.
Semin Immunopathol. 43:383–392. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
China NHCotPsRo: Notice on the issuance of
the overall plan for the implementation of ‘Category B and B
Management’ for the novel coronavirus infection, 2022.
|
|
20
|
Mi J, Wang J, Chen L, Guo Z, Lei H, Chong
MK, Talifu J, Yang S, Luotebula K, Ablikemu M, et al: Real-world
effectiveness of influenza vaccine against medical-attended
influenza infection during 2023/24 season in Ili Kazakh autonomous
prefecture, China: A test-negative, case-control study. Hum Vaccin
Immunother. 20(2394255)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sohrabi C, Alsafi Z, O'Neill N, Khan M,
Kerwan A, Al-Jabir A, Iosifidis C and Agha R: World Health
Organization declares global emergency: A review of the 2019 novel
coronavirus (COVID-19). Int J Surg. 76:71–76. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ye Z, Rochwerg B, Wang Y, Adhikari NK,
Murthy S, Lamontagne F, Fowler RA, Qiu H, Wei L, Sang L, et al:
Treatment of patients with nonsevere and severe coronavirus disease
2019: An evidence-based guideline. CMAJ. 192:E536–E545.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu L, Chen Y, Ma Y, Yang Z, Yang N, Deng
W, Chen Y, Sun Y, Li Y and Lin L: Clinical practice guideline on
treating influenza in adult patients with Chinese patent medicines.
Pharmacol Res. 160(105101)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Uyeki TM, Bernstein HH, Bradley JS,
Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA,
Hirshon JM, et al: Clinical practice guidelines by the infectious
diseases society of America: 2018 Update on diagnosis, treatment,
chemoprophylaxis, and institutional outbreak management of seasonal
influenzaa. Clin Infect Dis. 68:895–902. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chan KW, Wong VT and Tang SCW: COVID-19:
An update on the epidemiological, clinical, preventive and
therapeutic evidence and guidelines of integrative Chinese-western
medicine for the management of 2019 novel coronavirus disease. Am J
Chin Med. 48:737–762. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang X, Du RH, Wang R, Cao TZ, Guan LL,
Yang CQ, Zhu Q, Hu M, Li XY, Li Y, et al: Comparison of
hospitalized patients with ARDS caused by COVID-19 and H1N1. Chest.
158:195–205. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tersalvi G, Veronese G and Winterton D:
Emerging evidence of myocardial injury in COVID-19: A path through
the smoke. Theranostics. 10:9888–9889. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sabogal Piñeros YS, Bal SM, Dijkhuis A,
Majoor CJ, Dierdorp BS, Dekker T, Hoefsmit EP, Bonta PI, Picavet D,
van der Wel NN, et al: Eosinophils capture viruses, a capacity that
is defective in asthma. Allergy. 74:1898–1909. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liao D, Zhou F, Luo L, Xu M, Wang H, Xia
J, Gao Y, Cai L, Wang Z, Yin P, et al: Haematological
characteristics and risk factors in the classification and
prognosis evaluation of COVID-19: A retrospective cohort study.
Lancet Haematol. 7:e671–e678. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu
W, Xie J, Guan W, Liang W, Ni Z, et al: Longitudinal hematologic
and immunologic variations associated with the progression of
COVID-19 patients in China. J Allergy Clin Immunol. 146:89–100.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yang AP, Liu JP, Tao WQ and Li HM: The
diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19
patients. Int Immunopharmacol. 84(106504)2020.PubMed/NCBI View Article : Google Scholar
|
